KR890007738A - 파킨슨씨병 치료용 에르골린 유도체 - Google Patents

파킨슨씨병 치료용 에르골린 유도체 Download PDF

Info

Publication number
KR890007738A
KR890007738A KR1019880015110A KR880015110A KR890007738A KR 890007738 A KR890007738 A KR 890007738A KR 1019880015110 A KR1019880015110 A KR 1019880015110A KR 880015110 A KR880015110 A KR 880015110A KR 890007738 A KR890007738 A KR 890007738A
Authority
KR
South Korea
Prior art keywords
methyl
compound
parkinson
disease
treatment
Prior art date
Application number
KR1019880015110A
Other languages
English (en)
Inventor
부오나미찌 메틸데
페그랏시 로렌쪼
롯시 알레산드로
만테가니 세르지오
Original Assignee
죠르지오 올란도
팜이탈리아 카를로 에르바 에스.알.엘.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878727236A external-priority patent/GB8727236D0/en
Priority claimed from GB888822424A external-priority patent/GB8822424D0/en
Application filed by 죠르지오 올란도, 팜이탈리아 카를로 에르바 에스.알.엘. filed Critical 죠르지오 올란도
Publication of KR890007738A publication Critical patent/KR890007738A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

내용 없음

Description

파킨슨씨병 치료용 에르골린 유도체
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (7)

  1. 추체외로의 증상을 치료하는데 사용하기 위한 약제학적 조성물의 제조에 있어서 일반식(Ⅰ)의 화합물 또는 이의 약제학적으로 허용되는 염의 용도.
    상기식에서 R1은 수소원자 또는 메틸 그룹을 나타내고 ; R2및 R3는 각각 수소원자를 나타내거나 함께 화학결합을 나타내며 ; R4는 수소원자 또는 C1내지 C4알킬 그룹 또는 알릴 그룹을 나타내며 ; R5는 C1내지 C4알킬 그룹 또는 알릴 그룹을 나타내며 ; R6는 수소 또는 할로겐 원자를 나타낸다.
  2. 제1항에 있어서, 파킨슨씨병의 치료에 사용하기 위한 약제학적 조성물의 제조를 위한 용도.
  3. 제1항 또는 2항에 있어서, 일반식(Ⅰ)에서 R4가 메틸인 화합물의 용도.
  4. 제1항 내지 3항중 어느 한 항에 있어서, R5가 메틸인 화합물의 용도.
  5. 제1항 내지 4항중 어느 한 항에 있어서, 8-위치의 치환체가 β-배위로 존재하는 화합물의 용도.
  6. 제1항 내지 5항중 어느 한 항에 있어서, R6가 염소 또는 브롬 또는 수소인 화합물의 용도.
  7. 제1항 또는 2항에 있어서, 일반식(Ⅰ)의 화합물인 6-메틸-9,10-디데하이드로-8β-(3,5-디옥소-피페라진-1-일-메틸)에르골린의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880015110A 1987-11-20 1988-11-17 파킨슨씨병 치료용 에르골린 유도체 KR890007738A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB878727236A GB8727236D0 (en) 1987-11-20 1987-11-20 Antiparkinson ergoline derivatives
GB8727236 1987-11-20
GB888822424A GB8822424D0 (en) 1988-09-23 1988-09-23 Antiparkinson ergoline derivatives
GB8822424.1 1988-09-23

Publications (1)

Publication Number Publication Date
KR890007738A true KR890007738A (ko) 1989-07-05

Family

ID=26293081

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880015110A KR890007738A (ko) 1987-11-20 1988-11-17 파킨슨씨병 치료용 에르골린 유도체

Country Status (20)

Country Link
US (1) US4847253A (ko)
EP (1) EP0317269B1 (ko)
JP (1) JP2655706B2 (ko)
KR (1) KR890007738A (ko)
CN (1) CN1033182A (ko)
AU (1) AU602268B2 (ko)
CA (1) CA1312015C (ko)
DE (1) DE3868866D1 (ko)
DK (1) DK645788A (ko)
ES (1) ES2032570T3 (ko)
FI (1) FI885346A (ko)
GR (1) GR3004355T3 (ko)
HU (1) HU200557B (ko)
IE (1) IE61612B1 (ko)
IL (1) IL88392A (ko)
MY (1) MY103477A (ko)
NO (1) NO885166L (ko)
NZ (1) NZ227022A (ko)
PH (1) PH24515A (ko)
PT (1) PT89036B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE204278T1 (de) * 1992-12-24 2001-09-15 Pharmacia & Upjohn Spa Serotoninergische ergolin derivate
DE69426062T2 (de) * 1993-08-18 2001-03-22 Alcon Laboratories, Inc. Zusammensetzungen von ergolinderivaten zur behandlung des glaukoms
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
GB9407637D0 (en) 1994-04-18 1994-06-08 Erba Carlo Spa Serotoninergic abeo-ergoline derivatives
GB9603226D0 (en) * 1996-02-15 1996-04-17 Pharmacia Spa Heterocyclyl-ergoline derivatives
US6060483A (en) * 1996-06-27 2000-05-09 Pharmacia & Upjohn S.P.A. Antineurodegenerative ergoline derivatives
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
PT1426049E (pt) * 2002-12-02 2005-09-30 Sanol Arznei Schwarz Gmbh Administracao iontoforetica de rotigotina para o tratamento da doenca de parkinson
EP1547592A1 (en) * 2003-12-23 2005-06-29 Schwarz Pharma Ag Intranasal formulation of rotigotine
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
GB8501078D0 (en) * 1985-01-16 1985-02-20 Erba Farmitalia Piperazin-1-yl-ergo-line derivatives

Also Published As

Publication number Publication date
NZ227022A (en) 1991-01-29
DK645788A (da) 1989-05-21
AU602268B2 (en) 1990-10-04
AU2568488A (en) 1989-05-25
FI885346A0 (fi) 1988-11-18
CA1312015C (en) 1992-12-29
FI885346A (fi) 1989-05-21
ES2032570T3 (es) 1993-02-16
GR3004355T3 (ko) 1993-03-31
IL88392A (en) 1992-01-15
JP2655706B2 (ja) 1997-09-24
DE3868866D1 (de) 1992-04-09
CN1033182A (zh) 1989-05-31
DK645788D0 (da) 1988-11-18
HUT48463A (en) 1989-06-28
US4847253A (en) 1989-07-11
MY103477A (en) 1993-06-30
PH24515A (en) 1990-07-18
EP0317269A2 (en) 1989-05-24
IE883453L (en) 1989-05-20
JPH01153689A (ja) 1989-06-15
NO885166L (no) 1989-05-22
IL88392A0 (en) 1989-06-30
HU200557B (en) 1990-07-28
EP0317269B1 (en) 1992-03-04
PT89036A (pt) 1988-12-01
NO885166D0 (no) 1988-11-18
PT89036B (pt) 1993-02-26
EP0317269A3 (en) 1990-05-16
IE61612B1 (en) 1994-11-16

Similar Documents

Publication Publication Date Title
KR890007738A (ko) 파킨슨씨병 치료용 에르골린 유도체
KR880006206A (ko) 퀴나졸리논 유도체 및 이의 제조방법
KR890006599A (ko) 복소환 유도체, 그의 제법 및 이를 활성성분으로 함유하는 방사선 감응제 및 항비루스제
KR940007022A (ko) 피패리딘 유도체, 이것의 제법 및 치료에 있어서 이것의 이용
KR850003890A (ko) 1H-이미다조[4,5c]-퀴놀린-4-아민의 제조방법
KR930701169A (ko) 면역억제제로서의 3-페닐-5,6-디하이드로벤즈[c]아크리딘-7-카복실산 및 관련 화합물
KR870006039A (ko) 신규 티아졸 화합물, 그 제조방법 및 이 화합물을 함유하는 약학적 조성물
KR890000421A (ko) 치환된 인돌리논 유도체를 제조하는 향상된 방법
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
KR900006347A (ko) 살균성 플루오로퀴놀로닐 세펨
KR860700250A (ko) 신규 아미딘 화합물
KR900700098A (ko) 발기부전의 치료겸 진단용 플라복세이트 및 그 유도체
GR3004855T3 (ko)
KR930700502A (ko) 6-아미노옥타히드로인돌리진트리올 유도체
KR840003631A (ko) 아졸릴펜옥시- 테트라하이드로푸란-2-일리덴- 메탄의 제조방법
KR890006639A (ko) 벤조티아진 디옥사이드 유도체
KR920007995A (ko) 벤즈아미드 유도체
KR890008148A (ko) 새로운 세파로스포린 화합물 및 항균제
NO154391C (no) E 2-amino-naftalen-derivater.
KR880001596A (ko) 디하이드로피리딘 화합물-함유 뇌기능이상 치료제
KR900701273A (ko) 진토성 에르골린 유도체
KR890002188A (ko) 술펜아미드 유도체 및 그의 제조방법
KR890009901A (ko) 3-히드록시-2-(4-메톡시페닐)-5-(2-메틸아미노에틸)-2,3-디히드로-5h-1,5- 벤조티아제핀-4-온 유도체, 그의 제조 및 치료에의 이용
KR930021629A (ko) 피페라진 유도체
KR840006480A (ko) 유기화합물 및 이의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application